Trials / Completed
CompletedNCT06229444
Predict + Protect Study: Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to ILI
Predict + Protect: A Randomized Controlled Trial Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to Influenza-like Illness (ILI)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 17,043 (actual)
- Sponsor
- Evidation Health · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this prospective, digital randomized controlled trial is to evaluate the effectiveness of a predictive ILI detection algorithm and associated alerts during influenza season for adults living in the contigent United States. The main study objectives are to assess the effectiveness of predictive ILI detection algorithm and associated alerts on protective behaviors related to ILI and assess the accuracy of a predictive ILI detection algorithm using participant self-reported ILI symptoms and diagnosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | ILI Predictive Alerts, Reactive Content, and Proactive Content | Participants receive ILI-related education, feedback, and opportunities to self-monitor ILI symptoms, in addition they also receive alerts about potential ILI illness, and reactive and personalized content about protective health behaviors. |
| BEHAVIORAL | ILI Predictive Alerts, Reactive Content | Participants receive alerts about potential ILI illness, and reactive and personalized content about protective health behaviors. |
| BEHAVIORAL | Proactive Content | Participants receive ILI-related education, feedback, and opportunities to self-monitor ILI symptoms. |
| BEHAVIORAL | No Intervention | Participants will not receive predictive alerts or reactive content after reporting symptoms or proactive IILI-related health educational content |
Timeline
- Start date
- 2024-02-12
- Primary completion
- 2024-08-05
- Completion
- 2024-09-06
- First posted
- 2024-01-29
- Last updated
- 2024-09-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06229444. Inclusion in this directory is not an endorsement.